Contribution of computed tomography to relative costs in the operative management of patients with renal cell carcinoma.
Relative costs in 14 patients undergoing operative treatment for primary renal carcinoma were anlayzed to determine the contribution of "little ticket" items relative to so-called "high technology" items, such as computed tomography (CT). The major contributing categories of cost were daily room charges, physican fees, and charges for laboratory and pharmacy. In most of the categories, a large variation was encountered, primarily due to patient and disease-related factors. CT was a minor factor in cost.